Reding MT, Simpson M, Ducore J, Holme PA, Maas Enriquez M, Mancuso ME(2024) Long-term efficacy and safety of damoctocog alfa pegol prophylaxis in patients with haemophilia A aged 12-<18 years at enrolment into PROTECT VIII Acta Haematol(in press) DOI 10.1159/000538702, PubMed 38599195
Jørgensen OJ, Steineger JE, Hillarp A, Pareli Wåland E, Holme PA, Heimdal K, Dheyauldeen S(2023) Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management Laryngoscope Investig Otolaryngol, 9(1), e1196 DOI 10.1002/lio2.1196, PubMed 38362186
Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R(2024) Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A: Results of an interventional, post-marketing study Haemophilia, 30(2), 388-394 DOI 10.1111/hae.14930, PubMed 38229269
